Sharemaestro company-news research for Merit Medical Systems Inc (MMSI), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
NASDAQ
United States
Provisional evidence
Company news sentiment
Latest MMSI news and sentiment
Merit Medical Systems Inc
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
Current company news
Early balanced news score
15 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.
Observed headline tone63/100
→
Published 30-day score50/100
Latest source headline
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
TradingView · 07 Oct 2026 17:36
Older, less relevant and less reliable stories count for less. Confidence is shown separately.
What supports the score
15 current stories are mapped specifically to MMSI.
The score uses 3 publishers rather than depending on one outlet.
What limits the score
The stories agree, but freshness-weighted evidence is only 0.031.
Confidence is 16/100, below the threshold for a firm score.
50/100
News scoreEarly balanced news score
16/100
Confidencethin evidence
91%/100
Company news15 company stories
99/100
Story agreement1/100 difference
News history
Daily score and story count over 30 days
10 Sep25 Sep09 Oct
News scoreStory count50 baseline
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence1
0.031 after freshness weightingSource breadth60
3 independent publishersCompany relevance91
share tied directly to this companyFreshness46
recency-weighted evidenceAgreement99
how closely stories agreePublisher mix49
less reliance on one publisherPrice and news history
Weekly price and news-score history
Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.
26 completed price weeks15 comparable news-score weeks
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
10 Apr07 Jul02 Oct
Weekly close, indexedSentiment score
WeekNews scoreCloseWeekly move
02 Oct 202651USD 85.37-2.4%
25 Sep 202651USD 87.5+2.5%
18 Sep 202650USD 85.37-1.1%
11 Sep 202652USD 86.36-3.6%
04 Sep 202652USD 89.6-1.0%
28 Aug 202655USD 90.49-0.3%
21 Aug 202661USD 90.78+0.0%
14 Aug 202666USD 90.76+1.9%
Provisional evidence
News subjects
What is shaping the score
Market update509 stories · 60%
Earnings523 stories · 20%
Deals and strategy631 stories · 7%
Guidance501 stories · 7%
Macro sensitivity501 stories · 7%
Source mix
Where the evidence comes from
Simply Wall Street503 stories · 20%
finance.yahoo.com502 stories · 13%
Yahoo! Finance Canada502 stories · 13%
DirectorsTalk Interviews631 stories · 7%
Investing.com Canada631 stories · 7%
Intellectia AI411 stories · 7%
TradingView501 stories · 7%
Recurring subjects
Subjects appearing most often
Earnings7Life Sciences3Healthcare3Financial Markets3Earnings Growth3Inflation2Earnings Surprise2Value Stocks1Share Price1Revenue Growth1
Earlier readings
How the score has changed
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
13 Jul50 neutral07 Oct 23:59
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 07 Oct 23:59 | 50 | +0 | 26/100 (+10) | 15 (+1) | Provisional |
| 06 Oct 23:59 | 50 | +0 | 16/100 (-1) | 14 (+3) | Provisional |
| 05 Oct 23:59 | 50 | -1 | 17/100 (0) | 11 (0) | Provisional |
| 03 Oct 23:59 | 51 | +0 | 17/100 (-1) | 11 (0) | Provisional |
| 02 Oct 23:59 | 51 | +0 | 18/100 (0) | 11 (-1) | Provisional |
| 01 Oct 23:59 | 51 | -1 | 18/100 (-10) | 12 (-10) | Provisional |
| 22 Sep 23:59 | 52 | +0 | 28/100 (-2) | 22 (+1) | Provisional |
| 21 Sep 23:59 | 52 | +2 | 30/100 (+1) | 21 (-3) | Provisional |
Evidence behind the direction
What drives this reading?
Shares of weighted directional evidence in 15 retained current headlines. These weights already account for freshness, relevance and publisher limits; they are not additive points of the published score.
Which subjects lean each way
A subject can carry both supportive and cautious news.
SubjectCautious ← 0 → Constructive
Earnings1 story
0.0%58.3%
Deals and strategy1 story
0.0%41.4%
Market update1 story
0.2%0.0%
Each side uses the same scale: 0–58.3% of the retained directional evidence.
Where the influence comes from
58.3%largest publisher shareA concentrated reading can depend heavily on one publisher.
Publisher groups follow the scoring rules. Company disclosures share one group; syndicated stories are consolidated before weighting.
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
—Unscored
Market updateNot used in direction
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
Fresenius Medical Care AG & Co. FMS entered 2026 with improving profitability, accelerating execution of its transformation strategy and growing momentum in HighVolumeHDF and value-based care. However, persistent treatment volume weakness, looming reimbursement headwinds, regulatory press…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Fresenius Medical Care AG & Co. FMS entered 2026 with improving profitability, accelerating execution of its transformation strategy and growing momentum in HighVolumeHDF and value-based care. However, persistent treatment volume weakness, looming reimbursement headwinds, regulatory pressure in China and inflation-related cost risks continue to pose meaningful challenges to the company's long-term growth outlook. Shares of this Zacks Rank #3 (Hold) company have lost 5.9% so far this year compared with the industry's 4.9% decline. However, the S&P 500 Index has gained 13.1% over the same time f
- Published
- 07 Oct 2026 17:36
- News subject
- Market update
- Why this score
- Growth outlook challenged
- Company focus
- Shared story · 78%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 1.4d old
- Text assessed
- Available headline and article text
- Duplicates
- 2 consolidated
EarningsEarnings GrowthEarnings SurpriseHealthcareInflationOperating Income
—Unscored
EarningsNot used in direction
Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026
Merit Medical Systems, Inc. (NASDAQ: MMSI) announced it will release its financial results for the third quarter of 2026 on Thursday, October 29, 2026, after the stock market closes. The company will also host an investor conference call on the same day at 4:30 p.m. Eastern Time to discus…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Merit Medical Systems, Inc. (NASDAQ: MMSI) announced it will release its financial results for the third quarter of 2026 on Thursday, October 29, 2026, after the stock market closes. The company will also host an investor conference call on the same day at 4:30 p.m. Eastern Time to discuss the results. Merit Medical, founded in 1987, specializes in developing, manufacturing, and distributing proprietary medical devices for various interventional, diagnostic, and therapeutic procedures.
- Published
- 06 Oct 2026 20:26
- News subject
- Earnings
- Why this score
- No clear directional signal in the available text
- Company focus
- Shared story · 78%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 2.3d old
- Text assessed
- Available headline and article text
- Duplicates
- 2 consolidated
EarningsFinancial ResultsHealthcareLife Sciences
—Unscored
Market updateNot used in direction
HSIC or MMSI: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Henry Schein (HSIC) or Merit Medical (MMSI). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way to find grea…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Henry Schein (HSIC) or Merit Medical (MMSI). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits. Currently, both Henry Schein and Mer
- Published
- 06 Oct 2026 14:40
- News subject
- Market update
- Why this score
- Positive financial language
- Company focus
- Shared story · 78%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 2.6d old
- Text assessed
- Available headline and article text
- Duplicates
- 2 consolidated
EarningsEarnings GrowthEstimate RevisionsMedical Dental SuppliesShare PriceValue Stocks
—Unscored
Market updateNot used in direction
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
Merit Medical Systems, Inc. MMSI is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by solid product performance, global expansion and strategic M&A, is expected to contribute further. However, tariffs and trade policy headwinds a…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Merit Medical Systems, Inc. MMSI is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by solid product performance, global expansion and strategic M&A, is expected to contribute further. However, tariffs and trade policy headwinds and China macro pressure persist. This Zacks Rank #2 (Buy) company's shares have lost 1.2% in the year-to-date period against the industry's 4.7% growth and the S&P 500's 13.1% rise. The renowned medical device provider has a market capitalization of $5.10 billion. The company projects 10.4% growth for the next
- Published
- 06 Oct 2026 14:17
- News subject
- Market update
- Why this score
- Positive financial language
- Company focus
- Shared story · 78%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 2.6d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
EarningsEarnings GrowthEarnings Per ShareEarnings SurpriseGlobal ExpansionM A
—Unscored
Market updateNot used in direction
Merit Medical Systems Inc (MIL:1MMSI) Stock Price, Trades & News
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 05 Oct 2026 07:12
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 3.9d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
—Unscored
EarningsNot used in direction
MMSI: Margin Execution Matters More, Platform Growth Keeps The Bull Case Intact
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 03 Oct 2026 07:00
- News subject
- Earnings
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 5.9d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Learn Why The Bull Case For Merit Medical Systems Stock Could Change Following Q2 Growth Surge
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 02 Oct 2026 16:41
- News subject
- Market update
- Why this score
- Positive financial language
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 6.5d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
—Unscored
GuidanceNot used in direction
Merit Medical Systems (NasdaqGS:MMSI) Stock Forecast & Analyst Predictions
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 02 Oct 2026 07:00
- News subject
- Guidance
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 6.9d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Merit Medical Systems, Inc. (MMSI) Stock Price, News, Quote & History
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 01 Oct 2026 12:53
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 7.6d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
Macro sensitivityNot used in direction
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
The Zacks Medical – Dental Supplies industry is benefiting from several structural healthcare shifts. Demand continues to benefit from stable healthcare utilization, continued expansion of specialty medicines, increasing adoption of biologics and GLP-1 therapies, and migration toward outp…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
The Zacks Medical – Dental Supplies industry is benefiting from several structural healthcare shifts. Demand continues to benefit from stable healthcare utilization, continued expansion of specialty medicines, increasing adoption of biologics and GLP-1 therapies, and migration toward outpatient, home-based and community care. Distributors and manufacturers are increasingly monetizing technology through AI, automation, digital workflows and data-enabled services, improving productivity and strengthening customer relationships. The supply side is also becoming more sophisticated, with investment
- Published
- 01 Oct 2026 11:56
- News subject
- Macro sensitivity
- Why this score
- No clear directional signal in the available text
- Company focus
- Shared story · 78%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 7.7d old
- Text assessed
- Stored article
- Duplicates
- 1 consolidated
DentalFourth QuarterHealthcareInflationMedical SuppliesRevenue Growth
—Unscored
Market updateNot used in direction
Merit Medical Systems, Inc. (MMSI) Stock Price, News, Quote & History
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 22 Sep 2026 19:58
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 16.3d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 22 Sep 2026 07:00
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 16.9d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
63/100 tone
Merit Medical Systems, Inc. (MMSI), a healthcare sector player with a $5.1 billion market cap, shows strong operational performance with 9.50% revenue growth and an EPS of 2.43. Analysts are largely positive, with a consensus target price of $101.45, suggesting an 18.84% upside. The compa…
58.3% of directional evidence
Medium story strength
Scoring detailsDirect company coverage
Merit Medical Systems, Inc. (MMSI), a healthcare sector player with a $5.1 billion market cap, shows strong operational performance with 9.50% revenue growth and an EPS of 2.43. Analysts are largely positive, with a consensus target price of $101.45, suggesting an 18.84% upside. The company's focus on reinvesting earnings for growth, coupled with its global presence and diversified product portfolio, makes it an attractive opportunity for growth-oriented investors.
- Published
- 21 Sep 2026 08:48
- News subject
- Earnings
- Why this score
- Operating growth
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 44/100
- 30-day weight
- 58.3% of directional evidence · 17.8d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
EarningsFinancial MarketsLife Sciences
41/100 tone
Market update
MMSI PE Ratio & Valuation, Is MMSI Overvalued
Merit Medical Systems Inc (MMSI) is currently considered undervalued, with a forward PE ratio of 18.73, which is lower than its five-year average of 24.36. The fair price for MMSI is estimated to be between $96.25 and $121.55, suggesting it is undervalued by 11.2% compared to its current …
0.2% of directional evidence
Low story strength
Scoring detailsDirect company coverage
Merit Medical Systems Inc (MMSI) is currently considered undervalued, with a forward PE ratio of 18.73, which is lower than its five-year average of 24.36. The fair price for MMSI is estimated to be between $96.25 and $121.55, suggesting it is undervalued by 11.2% compared to its current price of $85.47. Despite a P/S ratio that is -10% above the industry average, its robust revenue growth of 9.51% is noted, though the premium is deemed unsustainable.
- Published
- 17 Sep 2026 15:52
- News subject
- Market update
- Why this score
- Negative valuation view
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Low · 33/100
- 30-day weight
- 0.2% of directional evidence · 21.5d old
- Text assessed
- Available headline and article text
- Duplicates
- 2 consolidated
EarningsFinancial Markets
63/100 tone
Merit Medical Systems Inc. discussed its ongoing strategic review and long-term growth plans at the Wells Fargo 21st Annual Healthcare Conference. The company reported strong Q2 growth, raised full-year guidance, and is evaluating eight platforms for potential changes and product rational…
41.4% of directional evidence
Medium story strength
Scoring detailsDirect company coverage
Merit Medical Systems Inc. discussed its ongoing strategic review and long-term growth plans at the Wells Fargo 21st Annual Healthcare Conference. The company reported strong Q2 growth, raised full-year guidance, and is evaluating eight platforms for potential changes and product rationalization, emphasizing "evolution, not revolution." CEO Martha Aronson highlighted core competencies, customer focus, and optimism for growth in areas like oncology, embolics, and a continued commitment to the China market despite challenges.
- Published
- 10 Sep 2026 13:40
- News subject
- Deals and strategy
- Why this score
- Guidance raised, Operating growth
- Company focus
- Shared story · 78%
- How it is used
- Direct company coverage
- Story strength
- Medium · 41/100
- 30-day weight
- 41.4% of directional evidence · 28.6d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
EarningsFinanceFinancial MarketsLife Sciences
Earlier company news
MMSI news archive
Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.
Older news is kept in the archive
There are 114 older MMSI headlines. Open one page at a time when you need them.
Open older archiveProvider matches checked
Provider mentions not used in the score
A news provider linked these stories to MMSI, but the headline and available text are not mainly about Merit Medical Systems Inc. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.
Provider mentions are kept separate
Open the list to see which provider matches were checked and left out of MMSI sentiment.
Open provider mentionsHow the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme. This is a rule-based evidence measure, not a calibrated probability.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.